» Articles » PMID: 25896313

Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1α and Akt Activation

Overview
Date 2015 Apr 22
PMID 25896313
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Diabetic cardiomyopathy (DCM) represents the major cause of morbidity and mortality among diabetics. Exercise has been reported to be effective to protect the heart from cardiac injury during the development of DCM. However, the potential cardioprotective effect of exercise in advanced DCM remains unclear.

Methods: Seven-week old male C57BL/6 wild-type or db/db mice were either subjected to a running exercise program for 15 weeks or kept sedentary. Cardiac function, myocardial apoptosis and fibrosis, and mitochondrial biogenesis were examined for evaluation of cardiac injury.

Results: A reduction in ejection fraction and fractional shortening in db/db mice was significantly reversed by exercise training. DCM induced remarkable cardiomyocyte apoptosis and increased ratio of Bax/Bcl-2 at the protein level. Meanwhile, DCM caused slightly myocardial fibrosis with elevated mRNA levels of collagen I and collagen III. Also, DCM resulted in a reduction of mitochondrial DNA (mtDNA) replication and transcription, together with reduced mtDNA content and impaired mitochondrial ultrastructure. All of these changes could be abolished by exercise training. Furthermore, DCM-associated inhibition of PGC-1α and Akt signaling was significantly activated by exercise, indicating that exercise-induced activation of PGC-1α and Akt signaling might be responsible for mediating cardioprotective effect of exercise in DCM.

Conclusion: Exercise preserves cardiac function, prevents myocardial apoptosis and fibrosis, and improves mitochondrial biogenesis in the late stage of DCM. Exercise-induced activation of PGC-1α and Akt signaling might be promising therapeutic targets for advanced DCM.

Citing Articles

Exercise in Diabetic Cardiomyopathy: Its Protective Effects and Molecular Mechanism.

Chen H, Guo L Int J Mol Sci. 2025; 26(4).

PMID: 40003929 PMC: 11855851. DOI: 10.3390/ijms26041465.


Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy-Challenges and Prospectives.

Khattab E, Kyriakou M, Leonidou E, Sokratous S, Mouzarou A, Myrianthefs M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861195 PMC: 11768626. DOI: 10.3390/ph18010134.


Physical Exercise: A Promising Treatment Against Organ Fibrosis.

Ma X, Liu B, Jiang Z, Rao Z, Zheng L Int J Mol Sci. 2025; 26(1.

PMID: 39796197 PMC: 11720236. DOI: 10.3390/ijms26010343.


Effects of Exercise Training on Cardiac Mitochondrial Functions in Diabetic Heart: A Systematic Review.

Shah I, Ishaq S, Lee S, Wu B Int J Mol Sci. 2025; 26(1.

PMID: 39795867 PMC: 11719559. DOI: 10.3390/ijms26010008.


The Role of Programmed Types of Cell Death in Pathogenesis of Heart Failure with Preserved Ejection Fraction.

Jankowski J, Kozub K, Kleibert M, Camlet K, Kleibert K, Cudnoch-Jedrzejewska A Int J Mol Sci. 2024; 25(18).

PMID: 39337409 PMC: 11432194. DOI: 10.3390/ijms25189921.